fashion -WSS

fashion

author：explore 2025-10-02 05:38:49 - browse：12

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Childbirth

WSS

Insmed lung disease drug hits target in key Phase 3 trial

Biohaven protein

Intellia reports positive results for its CRISPR

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Letters to First Opinion on caregivers, digital health, and more

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

entertainment

fashion

Wikipedia

Sports medicine is finally prioritizing gender equality

Akili, maker of video game for ADHD, to be acquired for 34 million

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Addiction doctors spar with methadone clinics over legislation

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Shifting the focus from loneliness to social health

Guidelines to prevent youth baseball injuries need more muscle

Heat waves linked to early deliveries, preterm births in new study

Apple is now the first public company to be valued at $3 trillion

Woman returns to dialysis after doctors remove transplanted pig kidney

focus

NIH documents show early flaws of $1.6 billion long Covid program

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

First Opinion Podcast: What happens when kids become caregivers?

BMI, flaws aside, is found to be useful estimate of body fat in youth

Ionis drug prevents swelling attacks due to hereditary angioedema

The Pandemic Treaty must support building strong health systems

Wikipedia

focus

Wikipedia

Wikipedia